For more information about how Lumina Intelligence can help you to navigate opportunities in the health, wellness and nutrition market please contact Ed Sibley direct on [email protected]
Treatment persistence has improved compared to earlier GLP-1 formulations, though discontinuation rates remain significant, often due to gastrointestinal side effects or cost concerns
GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)are prescribed for type 2 diabetes management and, in some formulations, for weight management in adults with obesity or overweight with comorbidities
The starting daily dose for the Wegovy pill is 1.5 milligrams, which can be ramped up to the maximum dose of 25 milligrams over 90 days
Microdosing compounded GLP-1s offers gentle support for your bodys essential systems, influencing energy, blood sugar stability, and cellular resilience
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
